Literature DB >> 10441006

SMAD genes in juvenile polyposis.

S Roth1, P Sistonen, R Salovaara, A Hemminki, A Loukola, M Johansson, E Avizienyte, K A Cleary, P Lynch, C I Amos, P Kristo, J P Mecklin, I Kellokumpu, H Järvinen, L A Aaltonen.   

Abstract

Juvenile polyposis (JP) is a dominantly inherited condition characterized by the development of multiple hamartomatous tumors, juvenile polyps, in the gastrointestinal tract. The aim of this study was to clarify the role of SMAD4 in JP. DNA from four unrelated JP kindreds and three sporadic JP cases was available for mutation screening. Two truncating defects (one in a familial and one in a sporadic case) and one missense change (in a familial case) that was absent in 55 control samples were detected. To study the possibility that germline mutations in other genes encoding different components of the TGF-beta signaling pathway may be present in these JP patients, mutation analyses of the SMAD2, SMAD3, and SMAD7 genes were also performed. No mutations of these genes were detected in any of the patients. Our results confirm that SMAD4 is a gene predisposing to JP and suggest the existence of further JP loci other than the SMAD2, SMAD3, or SMAD7 genes. Genes Chromosomes Cancer 26:54-61, 1999. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10441006     DOI: 10.1002/(sici)1098-2264(199909)26:1<54::aid-gcc8>3.0.co;2-d

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  16 in total

Review 1.  Lower gastrointestinal tract cancer predisposition syndromes.

Authors:  Neel B Shah; Noralane M Lindor
Journal:  Hematol Oncol Clin North Am       Date:  2010-12       Impact factor: 3.722

2.  Mutation screening in juvenile polyposis syndrome.

Authors:  Robert E Pyatt; Robert Pilarski; Thomas W Prior
Journal:  J Mol Diagn       Date:  2006-02       Impact factor: 5.568

Review 3.  Hamartomatous polyposis syndromes.

Authors:  Daniel Calva; James R Howe
Journal:  Surg Clin North Am       Date:  2008-08       Impact factor: 2.741

4.  Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes.

Authors:  X P Zhou; K Woodford-Richens; R Lehtonen; K Kurose; M Aldred; H Hampel; V Launonen; S Virta; R Pilarski; R Salovaara; W F Bodmer; B A Conrad; M Dunlop; S V Hodgson; T Iwama; H Järvinen; I Kellokumpu; J C Kim; B Leggett; D Markie; J P Mecklin; K Neale; R Phillips; J Piris; P Rozen; R S Houlston; L A Aaltonen; I P Tomlinson; C Eng
Journal:  Am J Hum Genet       Date:  2001-08-30       Impact factor: 11.025

5.  Common deletion of SMAD4 in juvenile polyposis is a mutational hotspot.

Authors:  James R Howe; Jason Shellnut; Brian Wagner; John C Ringold; Mohamed G Sayed; Abul F Ahmed; Patrick M Lynch; Christopher I Amos; Pertti Sistonen; Lauri A Aaltonen
Journal:  Am J Hum Genet       Date:  2002-03-27       Impact factor: 11.025

6.  Comprehensive analysis of SMAD4 mutations and protein expression in juvenile polyposis: evidence for a distinct genetic pathway and polyp morphology in SMAD4 mutation carriers.

Authors:  K L Woodford-Richens; A J Rowan; R Poulsom; S Bevan; R Salovaara; L A Aaltonen; R S Houlston; N A Wright; I P Tomlinson
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

7.  No TGFBRII germline mutations in juvenile polyposis patients without SMAD4 or BMPR1A mutation.

Authors:  L A A Brosens; W A van Hattem; M C E Kools; C Ezendam; F H Morsink; W W J de Leng; F M Giardiello; G J A Offerhaus
Journal:  Gut       Date:  2009-01       Impact factor: 23.059

8.  The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations.

Authors:  J R Howe; M G Sayed; A F Ahmed; J Ringold; J Larsen-Haidle; A Merg; F A Mitros; C A Vaccaro; G M Petersen; F M Giardiello; S T Tinley; L A Aaltonen; H T Lynch
Journal:  J Med Genet       Date:  2004-07       Impact factor: 6.318

9.  Prevalence of germline PTEN, BMPR1A, SMAD4, STK11, and ENG mutations in patients with moderate-load colorectal polyps.

Authors:  Joanne Ngeow; Brandie Heald; Lisa A Rybicki; Mohammed S Orloff; Jin Lian Chen; Xiuli Liu; Lisa Yerian; Joseph Willis; Heli J Lehtonen; Rainer Lehtonen; Jessica L Mester; Jessica Moline; Carol A Burke; James Church; Lauri A Aaltonen; Charis Eng
Journal:  Gastroenterology       Date:  2013-02-08       Impact factor: 22.682

10.  Identification of patients at risk for hereditary colorectal cancer.

Authors:  Nitin Mishra; Jason Hall
Journal:  Clin Colon Rectal Surg       Date:  2012-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.